CEE Legal Matters
In-depth coverage of the news and newsmakers that shape Europe's emerging markets
The amendments to the Bulgarian Public Health Act (PHA), introduced on 8 October 2024, are aimed at modernising the healthcare system, enhancing data management and improving patient care. They prioritise the transition to electronic health records (EHR), regulate telemedicine, and introduce a digital scheduling system for medical appointments. This article provides a high-level overview of the amendments.
Aksan has advised Pharmacontract on obtaining clearance from the Turkish Competition Board for the acquisition of unspecified subsidiaries in Italy.
B2RLaw, working with Pillsbury Winthrop Shaw Pittman, has advised Neuca and Humaneva on the sale of a minority stake in Humaneva to Viking Global Investors for USD 50 million. Clifford Chance advised Viking Global Investors.
Gide has advised Amethyst Radiotherapy Group on EUR 360 million refinancing from Ares Management and other financial institutions.
Cobalt has advised Change Ventures on co-leading a EUR 700,000 round for Certific, alongside Firstpick and Heartfelt VC.
As Pfizer’s Legal Director overseeing Greece, Cyprus, Malta, and Israel, Stathis Mihos explores EU health policy advancements and the complexities arising from the pandemic and examines how artificial intelligence is dynamically influencing lawyers’ work.
Greece’s vibrant life sciences sector is supported by a robust regulatory framework and expanding investment opportunities. In the following paragraphs, we will examine key aspects of product liability, intellectual property (IP), artificial intelligence (AI), and investment potential within the Greek life sciences landscape, highlighting the laws and regulations that shape the industry.
